Pharmena (WAR:PHR) Gross Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Pharmena Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Pharmena's Gross Profit for the three months ended in Mar. 2024 was zł0.01 Mil. Pharmena's Revenue for the three months ended in Mar. 2024 was zł0.01 Mil. Therefore, Pharmena's Gross Margin % for the quarter that ended in Mar. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

Warning Sign:

Pharmena SA gross margin has been in long-term decline. The average rate of decline per year is -3.5%.

The historical rank and industry rank for Pharmena's Gross Margin % or its related term are showing as below:

WAR:PHR' s Gross Margin % Range Over the Past 10 Years
Min: 51.19 Med: 67.13 Max: 72.29
Current: 59.68

During the past 13 years, the highest Gross Margin % of Pharmena was 72.29%. The lowest was 51.19%. And the median was 67.13%.

WAR:PHR's Gross Margin % is ranked worse than
50.87% of 747 companies
in the Biotechnology industry
Industry Median: 60.9 vs WAR:PHR: 59.68

Pharmena had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Pharmena was -3.50% per year.

Pharmena Gross Margin % Historical Data

The historical data trend for Pharmena's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmena Gross Margin % Chart

Pharmena Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross Margin %

Get a 7-Day Free Trial

66.67

51.19

51.48

54.33

59.40

Pharmena Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Gross Margin %	Get a 7-Day Free Trial															44.16	-275.00	-380.00	60.28	-

Competitive Comparison of Pharmena's Gross Margin %

For the Biotechnology subindustry, Pharmena's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmena's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmena's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Pharmena's Gross Margin % falls into.

Pharmena Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Pharmena's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )	=	Gross Profit (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	5.8	/	9.837
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(9.837 - 3.994)	/	9.837
	=	59.40 %

Pharmena's Gross Margin for the quarter that ended in Mar. 2024 is calculated as

Gross Margin % (Q: Mar. 2024 )	=	Gross Profit (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	0.01
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(0.01 - 0)	/	0.01
	=	N/A %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Pharmena (WAR:PHR) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Pharmena had a gross margin of N/A% for the quarter that ended in Mar. 2024 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

Pharmena Gross Margin % Related Terms

Thank you for viewing the detailed overview of Pharmena's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmena (WAR:PHR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmena SA (WAR:PHR) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Wolczanska 178, Lodz, POL, 90-530

Website

http://www.pharmena.pl

Pharmena SA produces cosmeceuticals and pharmaceuticals. The company's activity focuses on three areas such as research in the USA and Canada on the application of selected pyridinium salts in medicine in order to develop an anti-atherosclerosis drug on a global scale, Production and sales of innovative patented dermocosmetics and introduction into the market of an innovative dietary supplement for atherosclerosis prophylaxis. Its products include Menavitin, Dermena, Allerco and Thermi.